Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369961
Status:
COMPLETED
Last Update Posted:
2024-04-17
First Post:
2024-04-11
Brief Title:
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
Sponsor:
Chongqing University Cancer Hospital
Organization:
Chongqing University Cancer Hospital
Study Overview
Official Title:
A Retrospective Clinical Study on the Impact of Nutritional Status on the Analgesic Effect of Fentanyl Transdermal Patches in Cancer Pain Patients
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to investigate the correlation and quantitative relationship between the analgesic effect of fentanyl transdermal patches in cancer pain patients and their nutritional status
Detailed Description:
Cancer-related pain is one of the most common and unbearable symptoms among patients with malignant tumors Opioids are commonly used to treat moderate or severe cancer pain Among them fentanyl is a synthetic opioid with analgesic adjuvant with a 50100 times higher potency than morphine Due to its small molecular weight high lipid solubility and low irritation to the skin transdermal fentanyl TDF is formulated which is more convenient for patients with intestinal obstruction swallowing difficulties and intolerance to oral opioids According to some research the TDF demonstrated good cancer pain control for patients switching from morphine or oral oxycodone preparations and was well tolerated
However a part of patients still go through increased breakthrough pain sleep disturbances and even accompanied by anxiety and depression when using TDF Therefore early identification of cancer pain patients using TDF at risk of ineffectiveness is an essential step in increasing analgesic effectiveness and improving quality of life
Some studies discovered different clinical factors such as age gender serum albumin glomerular filtration rate kidney disease body mass index BMI total protein alanine aminotransferases have some influence on fentanyl serum concentration and the dose of TDF Furthermore the clinical factors seem to have a greater impact on the effectiveness of TDF than the genetic factors which may affect the liver metabolism of fentanyl Based on these results we aim to investigate the correlation and quantitative relationship between the analgesic effect of fentanyl transdermal patches in cancer pain patients and their nutritional status Our purpose is to help clinicians recognize and increase the analgesic effect of TDF according to the patients risk level
However a part of patients still go through increased breakthrough pain sleep disturbances and even accompanied by anxiety and depression when using TDF Therefore early identification of cancer pain patients using TDF at risk of ineffectiveness is an essential step in increasing analgesic effectiveness and improving quality of life
Some studies discovered different clinical factors such as age gender serum albumin glomerular filtration rate kidney disease body mass index BMI total protein alanine aminotransferases have some influence on fentanyl serum concentration and the dose of TDF Furthermore the clinical factors seem to have a greater impact on the effectiveness of TDF than the genetic factors which may affect the liver metabolism of fentanyl Based on these results we aim to investigate the correlation and quantitative relationship between the analgesic effect of fentanyl transdermal patches in cancer pain patients and their nutritional status Our purpose is to help clinicians recognize and increase the analgesic effect of TDF according to the patients risk level
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None